hrp0092p2-144 | Fetal, Neonatal Endocrinology and Metabolism (to include Hypoglycaemia) | ESPE2019
Salimi Dafsari Roschan
, Roper Marcia
, Groß Maximilian
, Wiechers Cornelia
, Sabir Hemmen
, Mayatepek Ertan
, Meissner Thomas
Background: The treatment of preterms with hyperinsulinemic hypoglycaemia is a well-known challenge. One of the difficulties of the therapy is the excessive application of intravenous fluids to compensate high carbohydrate needs. There are various drug alternatives such as glucagon, diazoxide or somatostatin analogues apart from intravenous glucose application.Hypothesis: Intravenous or continuous subcutaneous glucagon t...